{ "meta": { "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.", "terms": "https://open.fda.gov/terms/", "license": "https://open.fda.gov/license/", "last_updated": "2025-09-19", "results": { "skip": 0, "limit": 1, "total": 1 } }, "results": [ { "codes": [ { "uuid": "2a19a82d-060e-40c8-a00c-7b15f314eaaf", "code": "S01EA01", "comments": "ATC|SENSORY ORGANS|OPHTHALMOLOGICALS|ANTIGLAUCOMA PREPARATIONS AND MIOTICS|Sympathomimetics in glaucoma therapy|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=S01EA01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "25f3fae1-365b-4967-b4e1-231a35b0de87", "code": "C01CA24", "comments": "ATC|CARDIOVASCULAR SYSTEM|CARDIAC THERAPY|CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|Adrenergic and dopaminergic agents|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=C01CA24&showdescription=yes", "code_system": "WHO-ATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "cdbc95f9-6d64-4911-81f2-de85a7747eb4", "code": "A01AD01", "comments": "ATC|ALIMENTARY TRACT AND METABOLISM|STOMATOLOGICAL PREPARATIONS|STOMATOLOGICAL PREPARATIONS|Other agents for local oral treatment|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=A01AD01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "470857ec-1a12-451b-a44e-e0a1b27e0f17", "code": "B02BC09", "comments": "ATC|BLOOD AND BLOOD FORMING ORGANS|ANTIHEMORRHAGICS|VITAMIN K AND OTHER HEMOSTATICS|Local hemostatics|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=B02BC09&showdescription=yes", "code_system": "WHO-ATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "99ca7a32-200e-4868-87d9-a7275b13c7cc", "code": "R01AA14", "comments": "ATC|RESPIRATORY SYSTEM|NASAL PREPARATIONS|DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|Sympathomimetics, plain|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=R01AA14&showdescription=yes", "code_system": "WHO-ATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "0a4d2ec3-2be6-4ff6-9347-9e634b87e76d", "code": "N0000175552", "comments": "Established Pharmacologic Class [EPC]|alpha-Adrenergic Agonist [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175552", "code_system": "NDF-RT", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "691cc3f8-b622-4faf-ba3e-634603594e73", "code": "N0000175555", "comments": "Established Pharmacologic Class [EPC]|beta-Adrenergic Agonist [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175555", "code_system": "NDF-RT", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "3bacf94b-1fa4-4997-af3f-58f0c427730b", "code": "N0000175570", "comments": "Established Pharmacologic Class [EPC]|Catecholamine [EPC]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000175570", "code_system": "NDF-RT", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "844b4dbb-eb47-4de3-9fed-c2eba7d230cb", "code": "N0000000209", "comments": "Cellular or Molecular Interactions [MoA]|Receptor Interactions [MoA]|G-Protein-linked Receptor Interactions [MoA]|Adrenergic Receptor Interactions [MoA]|Adrenergic Agonists [MoA]|Adrenergic alpha-Agonists [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000000209", "code_system": "NDF-RT", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "ecd79023-7ee0-4045-a203-4f563f580687", "code": "R03AA01", "comments": "ATC|RESPIRATORY SYSTEM|DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|ADRENERGICS, INHALANTS|Alpha- and beta-adrenoreceptor agonists|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=R03AA01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "bb62942e-78e9-4ab8-9c9d-06fef8397b88", "code": "N0000007715", "comments": "Chemical Ingredients [Chemical/Ingredient]|Organic Chemicals [Chemical/Ingredient]|Amines [Chemical/Ingredient]|Biogenic Amines [Chemical/Ingredient]|Biogenic Monoamines [Chemical/Ingredient]|Catecholamines [Chemical/Ingredient]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000007715", "code_system": "NDF-RT", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "471d0bb0-6d1b-443a-9453-0020368aaeb5", "code": "QR03AK01", "comments": "VATC|DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|ADRENERGICS, INHALANTS|Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics|epinephrine and other drugs for obstructive airway diseases", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QR03AK01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "4234d5b2-5df8-46a9-9cf8-d493e9c19d31", "code": "QC01CA24", "comments": "VATC|CARDIAC THERAPY|CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES|Adrenergic and dopaminergic agents|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QC01CA24&showdescription=yes", "code_system": "WHO-VATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "16b655ed-ce52-47ad-a804-0d0b7903ffec", "code": "QB02BC09", "comments": "VATC|ANTIHEMORRHAGICS|VITAMIN K AND OTHER HEMOSTATICS|Local hemostatics|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QB02BC09&showdescription=yes", "code_system": "WHO-VATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "9e129f48-b321-42d6-ba86-e364d59c16e9", "code": "QR01AA14", "comments": "VATC|NASAL PREPARATIONS|DECONGESTANTS AND OTHER NASAL PREPARATIONS FOR TOPICAL USE|Sympathomimetics, plain|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QR01AA14&showdescription=yes", "code_system": "WHO-VATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "a5684d96-bfd3-49a1-b9a0-f8794363f484", "code": "QA01AD01", "comments": "VATC|STOMATOLOGICAL PREPARATIONS|STOMATOLOGICAL PREPARATIONS|Other agents for local oral treatment|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QA01AD01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "9368ecf5-38aa-4d94-aeec-f8fb0c809c04", "code": "N0000000245", "comments": "Cellular or Molecular Interactions [MoA]|Receptor Interactions [MoA]|G-Protein-linked Receptor Interactions [MoA]|Adrenergic Receptor Interactions [MoA]|Adrenergic Agonists [MoA]|Adrenergic beta-Agonists [MoA]", "type": "PRIMARY", "url": "https://nciterms.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=VA_NDFRT&code=N0000000245", "code_system": "NDF-RT", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "99773df3-6376-4388-978e-4960dbb30271", "code": "QR03AA01", "comments": "VATC|DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|ADRENERGICS, INHALANTS|Alpha- and beta-adrenoreceptor agonists|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QR03AA01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "2dcdd3e2-4426-4b51-a0e0-35aa551ca91b", "code": "QS01EA01", "comments": "VATC|OPHTHALMOLOGICALS|ANTIGLAUCOMA PREPARATIONS AND MIOTICS|Sympathomimetics in glaucoma therapy|epinephrine", "type": "PRIMARY", "url": "http://www.whocc.no/atcvet/atcvet_index/?code=QS01EA01&showdescription=yes", "code_system": "WHO-VATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "da87c94d-a403-477b-b933-686ffedd4c9a", "code": "51-43-4", "type": "PRIMARY", "url": "https://commonchemistry.cas.org/detail?cas_rn=51-43-4", "code_system": "CAS", "references": [ "49459341-ad37-462e-85ec-3d73d58f9755" ] }, { "uuid": "6c65aedb-7482-4983-99d0-4c712993b14d", "code": "C473", "type": "PRIMARY", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C473", "code_system": "NCI_THESAURUS", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "5718faed-0ed6-497c-9b40-a85dece9213d", "code": "D004837", "type": "PRIMARY", "url": "http://www.ncbi.nlm.nih.gov/mesh/68004837", "code_system": "MESH", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "5bee5e29-3c92-4da2-bcf0-8f6dee5949ba", "code": "03", "comments": "WHO ESSENTIAL MEDICINES LIST|Antiallergics and medicines used in anaphylaxis", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/31/?section=38#type99", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "037ca3a8-bb1c-4a90-842f-3f07a7c8b4b4", "code": "1.2 (LID/EPI)", "comments": "WHO ESSENTIAL MEDICINES LIST|Anaesthetics|Local anaesthetics", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/14/?section=31#type32", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "041b8678-37d3-4741-8712-a75af1dfc5f9", "code": "EPINEPHRINE", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Epinephrine", "code_system": "WIKIPEDIA", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "26647599-11c5-47e0-84c0-5f264525b246", "code": "21 CFR 346.12", "comments": "PART 346 -- ANORECTAL DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE|Subpart B--Active Ingredients|Sec. 346.12 Vasoconstrictor active ingredients.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=346.12", "code_system": "CFR", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "7226d40a-7e74-4d94-9b04-cf4f82d622c0", "code": "21 CFR 341.16", "comments": "PART 341 -- COLD, COUGH, ALLERGY, BRONCHODILATOR, AND ANTIASTHMATIC DRUG PRODUCTS FOR OVER-THE-COUNTER HUMAN USE|Subpart B--Active Ingredients|Sec. 341.16 Bronchodilator active ingredients.", "type": "PRIMARY", "url": "http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfCFR/CFRSearch.cfm?fr=341.16", "code_system": "CFR", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "79d17130-5e44-4968-84d0-9c93fed6ac95", "code": "12.2", "comments": "WHO ESSENTIAL MEDICINES LIST|Cardiovascular medicines|Antiarrhythmic medicines", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/31/?section=92#type100", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "117c82ee-e0c9-49e4-ada6-c100fd028bdd", "code": "21.5", "comments": "WHO ESSENTIAL MEDICINES LIST|Ophthalmological preparations|Mydriatics", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/31/?section=143#type101", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "680198b4-a1b8-4918-a4d6-8ffc58288562", "code": "25.1", "comments": "WHO ESSENTIAL MEDICINES LIST|Medicines acting on the respiratory tract|Antiasthmatic and medicines for chronic obstructive pulmonary disease", "type": "PRIMARY", "url": "http://prais.paho.org/medicine/31/?section=157#type99", "code_system": "WHO-ESSENTIAL MEDICINES LIST", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "899a03f3-81c0-4b35-909c-5ac2cacd7de2", "code": "R03AK01", "comments": "ATC|RESPIRATORY SYSTEM|DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES|ADRENERGICS, INHALANTS|Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics|epinephrine and other drugs for obstructive airway diseases", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=R03AK01&showdescription=yes", "code_system": "WHO-ATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "b8565c3d-c7c8-4024-9b41-45a6d2b8d8b9", "code": "S01EA51", "comments": "ATC|SENSORY ORGANS|OPHTHALMOLOGICALS|ANTIGLAUCOMA PREPARATIONS AND MIOTICS|Sympathomimetics in glaucoma therapy|epinephrine, combinations", "type": "PRIMARY", "url": "http://www.whocc.no/atc_ddd_index/?code=S01EA51&showdescription=yes", "code_system": "WHO-ATC", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "d48021d2-eeb2-444d-9f05-4ac5fabacc6f", "code": "2142", "type": "PRIMARY", "url": "https://extranet.who.int/soinn/mod/page/view.php?id=137&inn_n=2142", "code_system": "INN", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "b9778258-c169-4726-8522-b438ab35f533", "code": "200-098-7", "type": "PRIMARY", "url": "https://echa.europa.eu/substance-information/-/substanceinfo/100.000.090", "code_system": "ECHA (EC/EINECS)", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "95ad8e04-7eba-4fc6-9ab1-995533b19240", "code": "479", "type": "PRIMARY", "url": "http://www.guidetopharmacology.org/GRAC/LigandDisplayForward?ligandId=479", "code_system": "IUPHAR", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "cf52d172-f05d-4e94-ab1f-670ac207c116", "code": "EPINEPHRINE", "comments": "Other name: Adrenaline. (In certain countries the name Adrenaline is a trademark. In those countries this name may be used onlywhen applied to the product issued by the owners of the trademark.)Description: A white or almost white, microcrystalline powder; odourless.Solubility: Very slightly soluble in water; practically insoluble in ethanol (~750 g/l) TS, ether R and acetone R.Category: Sympathomimetic.Storage: Epinephrine should be kept in a hermetically closed container, protected from light.Additional information: Epinephrine gradually darkens in colour on exposure to air and light. Even in the absence of light,Epinephrine is gradually degraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures.RequirementsDefinition: Epinephrine contains not less than 98.5% and not more than 101.0% of C9H13NO3, calculated with reference to thedried substance.", "type": "PRIMARY", "url": "http://apps.who.int/phint/pdf/b/Jb.6.1.160.pdf", "code_system": "WHO INTERNATIONAL PHARMACOPEIA", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "4e6d3fe4-2426-4990-b757-c99f672ba545", "code": "3992", "comments": "RxNorm", "type": "PRIMARY", "url": "https://rxnav.nlm.nih.gov/REST/rxcui/3992/allProperties.xml?prop=all", "code_system": "RXCUI", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "ab310b28-97bb-4507-af2d-1dbb41e6b7d1", "code": "m4944", "comments": "Merck Index", "type": "PRIMARY", "url": "https://merckindex.rsc.org/monographs/m4944?q=authorize", "code_system": "MERCK INDEX", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "00ce1177-f1b2-4d1a-86ad-08fcecb1c5f2", "code": "51028-73-0", "type": "SUPERSEDED", "url": "https://commonchemistry.cas.org/detail?cas_rn=51028-73-0", "code_system": "CAS", "references": [ "4a3b6861-115b-44e3-aa15-d18c34118d49" ] }, { "uuid": "28ac6b8c-a46d-40b7-a70f-93b15165d7b1", "code": "DB00668", "type": "PRIMARY", "url": "http://www.drugbank.ca/drugs/DB00668", "code_system": "DRUG BANK", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "4593d3fe-98ef-4212-9f64-965c27c26c84", "code": "SUB06568MIG", "type": "PRIMARY", "code_system": "EVMPD", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "4677643b-57df-40fe-9739-d6451d952b48", "code": "CHEMBL679", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chembl/compound/inspect/CHEMBL679", "code_system": "ChEMBL", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "cc3227d7-f8ce-481a-af70-904ea3ea1c35", "code": "5816", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/compound/5816", "code_system": "PUBCHEM", "references": [ "56782ad5-cda7-45b0-8f77-b4f1744cf8e7" ] }, { "uuid": "77ce62a0-0b8e-49ad-3caf-e23fdc881416", "code": "4289", "type": "PRIMARY", "url": "https://pubchem.ncbi.nlm.nih.gov/source/hsdb/4289", "code_system": "HSDB", "references": [ "6d56eb94-d63d-f61d-9c0d-0c72e2397435" ] }, { "uuid": "1e21b93d-2980-2630-9be2-5b6893311167", "code": "DTXSID5022986", "type": "PRIMARY", "url": "https://comptox.epa.gov/dashboard/chemical/details/DTXSID5022986", "code_system": "EPA CompTox", "references": [ "6286d82c-1146-f783-9435-d065e123e416" ] }, { "uuid": "be1f0f51-0e56-5f43-e26b-d6ee088aa655", "code": "Epinephrine", "type": "PRIMARY", "url": "https://www.ncbi.nlm.nih.gov/books/n/lactmed/LM742/", "code_system": "LACTMED", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "cf5256ac-023d-6aaa-81ff-2e068c7e9dd8", "code": "133200", "comments": "ORPHAN DRUG|Designated|Treatment of squamous cell carcinoma of the head and neck.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=133200", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "4dc3bcf9-876c-f098-9e22-f0532697b831", "code": "134800", "comments": "ORPHAN DRUG|Designated|Treatment of metastatic malignant melanoma.", "type": "PRIMARY", "url": "https://www.accessdata.fda.gov/scripts/opdlisting/oopd/detailedIndex.cfm?cfgridkey=134800", "code_system": "FDA ORPHAN DRUG" }, { "uuid": "feb31854-6a39-90d9-a5c9-a1d5832cb160", "code": "C88516", "comments": "Physiology-Regulatory Factor[C1899]|Hormone[C2315]|Catecholamine", "type": "CONCEPT", "url": "https://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C88516", "code_system": "NCI_THESAURUS", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "664c05c8-2aee-460c-81aa-62044f557920", "code": "SUB130356", "type": "ALTERNATIVE", "code_system": "EVMPD" }, { "uuid": "90ebd9ea-c3e2-245f-0cfc-e17c0fc324e6", "code": "11046-0", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine [Mass/volume] in Urine", "type": "PRIMARY", "url": "https://loinc.org/11046-0/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "3851df93-0129-4f7d-0631-9df383ceed7c", "code": "2230-1", "comments": "LOINC|ACTIVE|CHEM|Plas|EPINEPHrine [Mass/volume] in Plasma", "type": "PRIMARY", "url": "https://loinc.org/2230-1/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "d29c94cd-0796-30b4-4746-c8d6182ffeed", "code": "24522-5", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine/Creatinine [Molar ratio] in Urine", "type": "PRIMARY", "url": "https://loinc.org/24522-5/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "843f7ac1-1ccd-018b-5f76-ff911c5651ae", "code": "44837-3", "comments": "LOINC|ACTIVE|CHEM|Urine|Epinephrine+Norepinephrine [Mass/volume] in 24 hour Urine", "type": "PRIMARY", "url": "https://loinc.org/44837-3/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "827ce250-7261-5a24-0b84-c9c978b70be9", "code": "2231-9", "comments": "LOINC|DEPRECATED|CHEM|Ser|Deprecated EPINEPHrine [Mass/volume] in Plasma", "type": "PRIMARY", "url": "https://loinc.org/2231-9/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "3bd666fb-1817-c43b-77f1-295157dc0b7b", "code": "2232-7", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine [Mass/time] in 24 hour Urine", "type": "PRIMARY", "url": "https://loinc.org/2232-7/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "796c9d92-4e3d-8e1c-ddcf-6ad7b219f663", "code": "24521-7", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine [Moles/volume] in Urine", "type": "PRIMARY", "url": "https://loinc.org/24521-7/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "63f3db5d-dc24-1f91-89c3-af2b264b4432", "code": "13734-9", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine/Creatinine [Mass Ratio] in Urine", "type": "PRIMARY", "url": "https://loinc.org/13734-9/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "6504267a-f7df-e13d-5f50-edec92d2f815", "code": "16111-7", "comments": "LOINC|ACTIVE|CHEM|Urine|Epinephrine+Norepinephrine [Mass/time] in 24 hour Urine", "type": "PRIMARY", "url": "https://loinc.org/16111-7/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "21090225-5cfe-78e8-0737-3d0794fcaf00", "code": "13735-6", "comments": "LOINC|ACTIVE|CHEM|Urine|Epinephrine+Norepinephrine/Creatinine [Mass Ratio] in Urine", "type": "PRIMARY", "url": "https://loinc.org/13735-6/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "3339cf56-2883-4d87-ba36-f91bc982ed0a", "code": "14711-6", "comments": "LOINC|ACTIVE|CHEM|Plas|EPINEPHrine [Moles/volume] in Plasma", "type": "PRIMARY", "url": "https://loinc.org/14711-6/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "a740dede-31ba-7ff0-9077-a5af835ed672", "code": "14712-4", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine [Moles/time] in 24 hour Urine", "type": "PRIMARY", "url": "https://loinc.org/14712-4/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "846b9220-915d-a569-999f-28c62b4b60b6", "code": "25908-5", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine [Moles/volume] in 24 hour Urine", "type": "PRIMARY", "url": "https://loinc.org/25908-5/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "d968b44e-0766-f88d-b241-5d44fc25bd6b", "code": "25909-3", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine/Creatinine [Molar ratio] in 24 hour Urine", "type": "PRIMARY", "url": "https://loinc.org/25909-3/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "dd03c59c-8afe-7d92-eed0-f97fdd016f95", "code": "32015-0", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine [Mass/volume] in 24 hour Urine", "type": "PRIMARY", "url": "https://loinc.org/32015-0/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "232105e9-0e4a-1562-8e09-b50654b89008", "code": "33874-9", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine/Creatinine [Molar ratio] in Urine collected for unspecified duration", "type": "PRIMARY", "url": "https://loinc.org/33874-9/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "f6fcf7a9-3733-41e1-9c63-caf515c5c8f7", "code": "43248-4", "comments": "LOINC|ACTIVE|CHEM|Urine|EPINEPHrine/Creatinine [Mass Ratio] in 24 hour Urine", "type": "PRIMARY", "url": "https://loinc.org/43248-4/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "cd6ac04f-e248-ae3f-7323-3739565faded", "code": "49552-3", "comments": "LOINC|ACTIVE|CHEM|Urine|Epinephrine+Norepinephrine [Mass/volume] in Urine", "type": "PRIMARY", "url": "https://loinc.org/49552-3/", "code_system": "LOINC", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "9d3d6b12-53a6-45e0-bb9c-86751e540d48", "code": "YKH834O4BH", "type": "PRIMARY", "code_system": "FDA UNII" }, { "uuid": "593706ab-709f-3fcc-4e39-46f47481ac5c", "code": "1028", "type": "PRIMARY", "url": "https://drugcentral.org/drugcard/1028", "code_system": "DRUG CENTRAL", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "716bfc63-67be-9d83-6f50-978c6c8d3217", "code": "28918", "type": "PRIMARY", "url": "https://www.ebi.ac.uk/chebi/chebiOntology.do?chebiId=CHEBI:28918", "code_system": "CHEBI", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "74cbb063-d591-9bfb-1f52-0addf1de11f9", "code": "Epinephrine (medication)", "type": "PRIMARY", "url": "https://en.wikipedia.org/wiki/Epinephrine_(medication)", "code_system": "WIKIPEDIA", "references": [ "8fa123c0-0fb6-b74d-1bbc-80a9f49bc46d" ] }, { "uuid": "1807db9d-ded7-d8f9-80fd-531cf9f5690e", "code": "1236970", "type": "PRIMARY", "url": "https://store.usp.org/product/1236970", "code_system": "RS_ITEM_NUM", "references": [ "fc7b6176-f205-b69c-a87a-d69f3327791a" ] }, { "uuid": "ee8a3551-0725-0200-f795-a9b597feda97", "code": "62786", "type": "PRIMARY", "url": "https://dtp.cancer.gov/dtpstandard/servlet/dwindex?searchtype=NSC&outputformat=html&searchlist=62786", "code_system": "NSC", "references": [ "aba48e58-f3b4-a152-72ec-7f2131f59c1a" ] }, { "uuid": "f74b4f30-a419-4482-bcbb-6ec9d8356d62", "code": "YKH834O4BH", "type": "PRIMARY", "url": "https://dailymed.nlm.nih.gov/dailymed/search.cfm?adv=1&query=YKH834O4BH", "code_system": "DAILYMED", "references": [ "c3a434fe-bd9c-a9e0-ee14-58fd85c81f0b" ] }, { "uuid": "822e1c6e-5d35-59d4-3b33-9d76dae069da", "code": "100000092380", "type": "PRIMARY", "code_system": "SMS_ID", "references": [ "62ea4cad-989c-fdcb-1b52-e2bd17b07155" ] } ], "substance_class": "chemical", "references": [ { "uuid": "04a55222-0a1b-47ae-8564-e8fa7edbc84b", "citation": "EPINEPHRINE [ORANGE BOOK]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "d19f42ee-5803-4c8d-9224-c7c1574517aa", "citation": "ADRENALINE [MART.]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "ca410787-02cd-43df-8ec6-69067eb73b26", "citation": "EPINEPHRINE [MI]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "a6c2071b-840d-49d9-9a61-f7bba9069138", "citation": "EPINEPHRINE [HSDB]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "98caac79-4064-4cb7-905e-991b3b10a671", "citation": "EPINEPHRINE [WHO-DD]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "b248fa0f-86d1-4184-a562-9ed63e28f188", "citation": "EPINEPHRINE [VANDF]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "751006fd-a2ea-4596-b5e7-12638f7067b6", "citation": "EPINEPHRINE [WHO-IP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "65ad28e9-b032-4a79-b036-72396b594281", "citation": "USP Dictionary 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE", "AUTO_SELECTED" ] }, { "uuid": "88907120-abe9-4e83-9e5a-2008e8490d10", "citation": "HPUS 2004", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "7dee21d2-6c68-4039-8544-c8fcdc10c280", "citation": "DL", "doc_type": "HOMEOPATHIC PHARMACOPOEIA US", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "207eedf5-6b33-4179-8da5-c3256ba4d5e6", "citation": "USP DICTIONARY 2009", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "12708f41-8608-4474-a6f2-89d33cc5470c", "citation": "BAN", "doc_type": "BAN", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "2e812d15-cdd0-40c6-8cd7-6e79aeabd39a", "citation": "ORANGE BOOK", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "8d30f07d-e236-4720-8cbc-d53fdd4603b1", "citation": "USP DICTIONARY 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "07a707a7-2266-4672-8562-654b2b0816d9", "citation": "MERCK", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "7999319a-8fe6-4644-bb1c-5cc5030b674e", "citation": "FDA-SRS 2010", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "4c6def24-5228-4b15-b039-8b081d863d82", "citation": "INN Proposed List 16", "url": "https://www.who.int/medicines/publications/druginformation/innlists/PL16.pdf", "doc_type": "INN_LIST", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "ea720735-870c-4b34-b255-dab378081417", "citation": "EP 7.2", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "30674fd0-b3e9-41e5-85ad-cb18c11aaf26", "citation": "USP 33", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a5604353-c3f5-41e0-8231-9f453677dbd9", "citation": "HPUS", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "c3ee0ef4-02bb-467c-a118-40d321ecf18a", "citation": "HPUS 2011", "doc_type": "HOMEOPATHIC PHARMACOPOEIA US", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "1cbe8068-a309-4a5d-8789-6f41ee8a1ec5", "citation": "Drugs@FDA 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "ff7e3222-1eeb-426d-a184-3a4aab8bf6b5", "citation": "Drugs@FDA 2012", "doc_type": "DRUGS@FDA", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "1d09c33f-4197-459b-a5bb-69f98a85762e", "citation": "ORANGE BOOK 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "fb9891f4-3438-47d3-bcc8-a7b0c4d1470d", "citation": "MARTINDALE 2011", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "5f5aa7bd-9fae-405d-8bab-8080c35ea01a", "citation": "MERCK INDEX", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "1e6d93f5-3541-4489-b18f-ba2e15a7f1bd", "citation": "HSDB", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "928f6519-b307-43ed-95ff-b2003f8dc087", "citation": "WHO-DD", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "d5448efc-a5ce-4e54-9ae9-e861babf16f5", "citation": "NDF-RT", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "88c3f270-40fb-421b-b6f7-256009e5f6c4", "citation": "http://edudrugs.com/S/Sus-Phrine.html", "url": "http://edudrugs.com/S/Sus-Phrine.html", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "a57ed791-c2da-4ccd-a690-f4b5a73e3b48", "citation": "WHO-IP", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "d67cacab-63eb-4210-be9b-64f551c0631e", "citation": "SCIFINDER", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "eb7ca244-8071-4c72-bbf9-1bcfc53e71ac", "citation": "http://www.drugs.com/pro/twinject-auto-injector.html", "url": "http://www.drugs.com/pro/twinject-auto-injector.html", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "f8c2f7d2-e6b0-4a61-9616-986001b1b81f", "citation": "STN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN" ] }, { "uuid": "56782ad5-cda7-45b0-8f77-b4f1744cf8e7", "citation": "SRS CODE IMPORT", "doc_type": "SRS", "public_domain": true, "document_date": 1493389690000, "tags": [ "NOMEN" ] }, { "uuid": "8645e24f-597d-4b44-9332-d9f76865e359", "citation": "SRS import [YKH834O4BH]", "url": "http://fdasis.nlm.nih.gov/srs/srsdirect.jsp?regno=YKH834O4BH", "doc_type": "SRS", "public_domain": true, "document_date": 1493389690000, "tags": [ "NOMEN" ] }, { "uuid": "ff6dfd07-3e5d-4811-a885-fb4c38083bc8", "citation": "EPINEPHRINE [INN]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "656a1959-3b43-4ee1-a16b-6914a6cf10fc", "citation": "ADRENALINE [EP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "fa492250-e584-4ad5-83ab-d71565c3b4e6", "citation": "EPINEPHRINE [USP]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "0f7c5e69-4f0e-42fe-ac17-89d7408a7cf7", "citation": "ADRENALINUM [HPUS]", "doc_type": "SRS_LOCATOR", "public_domain": true }, { "uuid": "95a25dff-f394-aea4-6c23-f472d41ce9db", "citation": "Drugs@FDA", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/207534lbl.pdf", "doc_type": "DRUGS@FDA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE", "NOMEN" ] }, { "uuid": "201ab365-9702-1291-0b53-c9036a25dd7f", "citation": "JAN", "doc_type": "SRS", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "6d56eb94-d63d-f61d-9c0d-0c72e2397435", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search2/r?dbs+hsdb:@term+@rn+@rel+51-43-4", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "6286d82c-1146-f783-9435-d065e123e416", "citation": "WEBSITE", "url": "https://comptox.epa.gov/dashboard/dsstoxdb/results?utf8=%E2%9C%93&search=51-43-4", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4bad046b-0d10-c8a7-f601-84faab0552df", "citation": "WEBSITE", "url": "https://toxnet.nlm.nih.gov/cgi-bin/sis/search/r?dbs+lactmed:@term+@rel+@rn+51-43-4", "doc_type": "WEBSITE", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "ad3ecfe8-4242-0ae1-befa-365f786b3ec2", "citation": "https://www.drugbank.ca/drugs/DB00668", "doc_type": "WEBSITE", "public_domain": true }, { "uuid": "fc7b6176-f205-b69c-a87a-d69f3327791a", "doc_type": "SYSTEM", "public_domain": true }, { "uuid": "c866a464-6f9d-549b-7568-b5b2d28528c9", "citation": "EP Adrenaline MONOGRAPH 07/2008:2303", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "4a3b6861-115b-44e3-aa15-d18c34118d49", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "49459341-ad37-462e-85ec-3d73d58f9755", "citation": "STN", "doc_type": "STN (SCIFINDER)", "public_domain": true }, { "uuid": "eee5741a-3d81-4234-8ec4-0a3d4d83afc2", "citation": "USP42-NF37 2S - 9155, Epinephrine Monograph", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "39b0aa3e-c641-42f8-856b-13f3f77f6605", "citation": "USP42-NF37 2S - 9155, Epinephrine Monograph", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "de93fe74-07ce-4732-9dc3-04cdc7c38c36", "citation": "USP42-NF37 2S - 9155, Epinephrine Monograph", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "94260a36-5da0-b601-7644-4d11b699721b", "citation": "USP42-NF37 2S - 9155", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "c5e2eb76-ff2f-e98c-6eb7-71796395db61", "citation": "European Pharmacopoeia Online 9.8, Adrenaline Monograph", "doc_type": "EP", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "8fa123c0-0fb6-b74d-1bbc-80a9f49bc46d", "citation": "WIKI", "doc_type": "WIKI", "public_domain": true }, { "uuid": "c4190628-c011-fc7e-68be-fb2353a4db37", "citation": "USP-RS", "doc_type": "USPNF", "public_domain": true }, { "uuid": "03958e06-9059-9d51-a7e0-53a996065988", "citation": "EP 10.5", "doc_type": "EP", "public_domain": true }, { "uuid": "4836c49b-ffa4-4753-a3e9-1124d3171c8d", "citation": "EP Adrenaline MONOGRAPH 07/2008:2303", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "1d37ae72-daea-4dcb-acc2-0e48199839ed", "citation": "EP 10.6", "doc_type": "EP", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "a5a0cfe2-2cf3-4661-9384-28b40e98d115", "citation": "EP Adrenaline MONOGRAPH 07/2008:2303", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "9ff55d09-4243-4f13-a7c5-c9bb7150938d", "citation": "EP Adrenaline MONOGRAPH 07/2008:2303", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "5183b7df-6050-541b-9a7f-ec9606bb0d6f", "citation": "USP/NF", "doc_type": "USPNF", "public_domain": true }, { "uuid": "e452b501-ed5a-49ec-ad6e-7e7a38a5dc5a", "citation": "EP Adrenaline MONOGRAPH 07/2008:2303", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "a766444f-4057-49f3-b010-25c5a5848493", "citation": "EP 10.6", "doc_type": "EP", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "2a7df67d-275a-4974-bebf-e31d55e0fc77", "citation": "EP Adrenaline MONOGRAPH 07/2008:2303", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "d9418190-9574-42dc-bd0b-ab9757ca2612", "citation": "LaBrosse, Elwood H., et al. \"Metabolism of 7-H 3-epinephrine-d-bitartrate in normal young men.\" The Journal of Clinical Investigation 40.2 (1961): 253-260.", "url": "http://www.ncbi.nlm.nih.gov/pmc/articles/PMC290717/pdf/jcinvest00301-0097.pdf", "doc_type": "JA", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "b9c4656f-7458-4161-9a43-c9bf456f2e8e", "citation": "Männl, Heinrich FK, Klaus Hempel, and Wolfgang Kübler. \"Catechol-O-methyl transferase in human erythrocytes.\" Naunyn-Schmiedeberg's archives of pharmacology 272 (1972): 265-276.", "url": "https://link.springer.com/article/10.1007/BF00499038", "doc_type": "JA", "public_domain": true }, { "uuid": "7839cf30-eb58-466b-bb59-b27aeabd7439", "citation": "Hoffmann, C., et al. \"Comparative pharmacology of human β-adrenergic receptor subtypes—characterization of stably transfected receptors in CHO cells.\" Naunyn-Schmiedeberg's archives of pharmacology 369 (2004): 151-159.", "url": "https://link.springer.com/article/10.1007/s00210-003-0860-y", "doc_type": "JA", "public_domain": true }, { "uuid": "aba48e58-f3b4-a152-72ec-7f2131f59c1a", "citation": "NCI", "doc_type": "NCI DRUG DICTIONARY", "public_domain": true }, { "uuid": "89496026-ac09-8e5a-f74e-346787dfdd43", "citation": "WHO-DD", "doc_type": "WHO DRUG DICTIONARY", "public_domain": true }, { "uuid": "c3a434fe-bd9c-a9e0-ee14-58fd85c81f0b", "citation": "DailyMed", "doc_type": "DAILYMED", "public_domain": true }, { "uuid": "62ea4cad-989c-fdcb-1b52-e2bd17b07155", "citation": "EU-SRS", "doc_type": "EMA LIST", "public_domain": true }, { "uuid": "0c9273f5-04b2-4a31-8d06-42f27740172e", "citation": "Erickson, Jeffrey D., et al. \"Distinct pharmacological properties and distribution in neurons and endocrine cells of two isoforms of the human vesicular monoamine transporter.\" Proceedings of the National Academy of Sciences 93.10 (1996): 5166-5171.", "url": "https://www.pnas.org/doi/pdf/10.1073/pnas.93.10.5166", "doc_type": "JA", "public_domain": true }, { "uuid": "4500df32-260e-4409-862c-15e811c99151", "citation": "USP42-NF37 2S - 9155, Epinephrine Monograph", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "df2e7254-5fab-4549-842d-208270648524", "citation": "Updated Information | Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs); Table 1", "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/updated-information-recommended-acceptable-intake-limits-nitrosamine-drug-substance-related", "doc_type": "WEB PAGE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "f09e2ba4-0956-4e44-b70c-ddc93e8d53dc", "citation": "EP Adrenaline MONOGRAPH 07/2008:2303", "doc_type": "EUROPEAN PHARMACOPEIA", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "34fa778d-11dd-4891-b0f4-23ab67738185", "citation": "EP 10.6", "doc_type": "EP", "public_domain": true, "tags": [ "NOMEN", "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "41d3f380-a535-4d54-b4a9-ac124af3065b", "citation": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214697s000lbl.pdf", "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2024/214697s000lbl.pdf", "doc_type": "DRUGS@FDA", "public_domain": true }, { "uuid": "516e0f30-102e-4af7-afa7-58c0904afdd9", "citation": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/2338", "url": "https://www.eurofinsdiscovery.com/catalogmanagement/viewItem/2338", "doc_type": "ASSAY REFERENCE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "42c3569c-cf3b-4b4e-a438-61cb599eadc1", "citation": "USP42-NF37 2S - 9155, Epinephrine Monograph", "doc_type": "USPNF", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] }, { "uuid": "dda18a06-ba93-4fbf-b498-7caf1f8c8415", "citation": "Updated Information | Recommended Acceptable Intake Limits for Nitrosamine Drug Substance-Related Impurities (NDSRIs); Table 1", "url": "https://www.fda.gov/regulatory-information/search-fda-guidance-documents/updated-information-recommended-acceptable-intake-limits-nitrosamine-drug-substance-related", "doc_type": "WEB PAGE", "public_domain": true, "tags": [ "PUBLIC_DOMAIN_RELEASE" ] } ], "definition_type": "PRIMARY", "moieties": [ { "uuid": "82f1b665-bc22-4036-8dcc-f95060aa8dbe", "id": "82f1b665-bc22-4036-8dcc-f95060aa8dbe", "molfile": "\n Marvin 01132106472D \n\n 13 13 0 0 1 0 999 V2000\n 7.6832 -5.0870 0.0000 C 0 0 1 0 0 0 0 0 0 1 0 0\n 7.6832 -4.2602 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 8.4043 -5.4911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 9.1162 -5.0870 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 9.8328 -5.4819 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 6.9896 -5.4957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 6.2730 -5.0870 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.5565 -5.4957 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 5.5565 -6.3225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 4.8491 -6.7314 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 6.2730 -6.7314 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 6.2730 -7.5489 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 6.9896 -6.3225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 1 2 1 1 0 0 0\n 3 1 1 0 0 0 0\n 1 6 1 0 0 0 0\n 4 3 1 0 0 0 0\n 5 4 1 0 0 0 0\n 7 6 1 0 0 0 0\n 6 13 2 0 0 0 0\n 8 7 2 0 0 0 0\n 9 8 1 0 0 0 0\n 10 9 1 0 0 0 0\n 9 11 2 0 0 0 0\n 12 11 1 0 0 0 0\n 11 13 1 0 0 0 0\nM END", "smiles": "CNC[C@@H](c1ccc(c(c1)O)O)O", "formula": "C9H13NO3", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "count_amount": { "type": "MOL RATIO", "average": 1, "units": "MOL RATIO", "uuid": "76039b09-f01a-4a31-9074-aa596986fb29" }, "defined_stereo": 1, "ez_centers": 0, "molecular_weight": "183.2048", "optical_activity": "UNSPECIFIED", "stereo_centers": 1 } ], "definition_level": "COMPLETE", "uuid": "bcc0057b-8ef0-47d3-9049-2b5ef6f2c6c7", "version": "162", "structure": { "id": "3d7f6400-eed2-4d56-bd17-61c35e569f90", "molfile": "\n Marvin 01132103152D \n\n 13 13 0 0 1 0 999 V2000\n 14.9107 -4.4878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 14.1941 -4.8968 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 13.4776 -4.4878 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 12.7702 -4.8968 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 13.4776 -3.6610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 14.1941 -3.2523 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 14.9107 -3.6610 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 15.6043 -3.2523 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0\n 15.6043 -2.4255 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 16.3254 -3.6564 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 17.0373 -3.2523 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0\n 17.7539 -3.6472 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0\n 14.1941 -5.7142 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0\n 2 1 1 0 0 0 0\n 3 2 2 0 0 0 0\n 4 3 1 0 0 0 0\n 3 5 1 0 0 0 0\n 5 6 2 0 0 0 0\n 6 7 1 0 0 0 0\n 7 1 2 0 0 0 0\n 8 7 1 0 0 0 0\n 8 9 1 1 0 0 0\n 10 8 1 0 0 0 0\n 11 10 1 0 0 0 0\n 12 11 1 0 0 0 0\n 13 2 1 0 0 0 0\nM END", "smiles": "CNC[C@@H](c1ccc(c(c1)O)O)O", "formula": "C9H13NO3", "atropisomerism": "No", "charge": 0, "count": 1, "stereochemistry": "ABSOLUTE", "defined_stereo": 1, "ez_centers": 0, "molecular_weight": "183.2048", "optical_activity": "( - )", "references": [ "65ad28e9-b032-4a79-b036-72396b594281", "8645e24f-597d-4b44-9332-d9f76865e359", "4c6def24-5228-4b15-b039-8b081d863d82" ], "stereo_centers": 1 }, "unii": "YKH834O4BH", "relationships": [ { "uuid": "54d9836b-cd15-4391-bc7c-29d09f99e8cb", "amount": { "uuid": "59b34acb-9a2e-468e-ab10-2971a44b53fe" }, "type": "ACTIVE MOIETY", "related_substance": { "uuid": "890a297a-bce8-4791-9934-2cf2e657ffee", "refuuid": "bcc0057b-8ef0-47d3-9049-2b5ef6f2c6c7", "name": "Epinephrine", "unii": "YKH834O4BH", "linking_id": "YKH834O4BH", "ref_pname": "Epinephrine", "substance_class": "reference" } }, { "uuid": "6efc2917-0a18-4127-b293-83b9cd8acd44", "amount": { "uuid": "ff4fed4b-048e-4b21-a301-fcb61a9089de" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "49bf288e-a2b4-4ff8-b21c-527c8c340296", "refuuid": "b2b0b238-b366-4e41-8c5c-a04176b7b746", "name": "EPINEPHRINE BITARTRATE", "unii": "30Q7KI53AK", "linking_id": "30Q7KI53AK", "ref_pname": "EPINEPHRINE BITARTRATE", "substance_class": "reference" } }, { "uuid": "168ebac8-7d6e-4a07-b1b3-958ec28fc9a2", "amount": { "uuid": "09bfa12e-c687-4389-9d21-4a677845da7d" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "a821f370-dc25-4839-ba68-4507bc779612", "refuuid": "3fcf6f74-4a2b-44fb-aa77-663a4a8b8b5d", "name": "EPINEPHRINE SULFATE", "unii": "CM4IBP5LLV", "linking_id": "CM4IBP5LLV", "ref_pname": "EPINEPHRINE SULFATE", "substance_class": "reference" } }, { "uuid": "9958c878-2464-46da-a2f7-44c02c9c76b2", "amount": { "uuid": "f5a578b0-fa71-44a4-be33-4a7c559de248" }, "type": "METABOLITE INACTIVE->PARENT", "mediator_substance": { "uuid": "0e4a073f-51d4-47ce-8c7c-ffecdc3e652c", "refuuid": "46a76c73-550a-4aab-ad26-460b6a357de9", "name": "CATECHOL O-METHYLTRANSFERASE", "unii": "22Q832K2UN", "linking_id": "22Q832K2UN", "ref_pname": "CATECHOL O-METHYLTRANSFERASE", "substance_class": "reference" }, "references": [ "b9c4656f-7458-4161-9a43-c9bf456f2e8e" ], "related_substance": { "uuid": "42361894-99f0-4468-a3b1-a1d4a61ce8a8", "refuuid": "7086deb6-ac64-4d15-9c7e-e57c50776b45", "name": "METANEPHRINE, (-)-", "unii": "17283JVN9V", "linking_id": "17283JVN9V", "ref_pname": "METANEPHRINE, (-)-", "substance_class": "reference" } }, { "uuid": "dd326b97-404c-4e59-b848-b8699b05a934", "amount": { "uuid": "f3ac5e95-fc01-48ba-b0ab-13a2a9894c01" }, "type": "METABOLITE INACTIVE->PARENT", "references": [ "d9418190-9574-42dc-bd0b-ab9757ca2612" ], "related_substance": { "uuid": "29fa47b9-27b7-4a3d-a5e2-30de0733dd68", "refuuid": "3b93db7c-3f12-4cc3-8dad-15e2b8405578", "name": "METANEPHRINE SULFATE, (-)-", "unii": "ZB2866EQ44", "linking_id": "ZB2866EQ44", "ref_pname": "METANEPHRINE SULFATE, (-)-", "substance_class": "reference" } }, { "uuid": "65c92c3c-ce9f-4066-a573-f8205a5c8418", "amount": { "uuid": "1f01cf5e-0582-4cad-9690-727f3928dfbe" }, "type": "METABOLITE INACTIVE->PARENT", "references": [ "d9418190-9574-42dc-bd0b-ab9757ca2612" ], "related_substance": { "uuid": "a4bbc1ab-1cb5-40ab-bad2-bb60b31413c7", "refuuid": "0f9a4fea-8b87-46f0-bc1e-c285381d3b96", "name": "EPINEPHRINE 4-SULFATE", "unii": "T074675S0E", "linking_id": "T074675S0E", "ref_pname": "EPINEPHRINE 4-SULFATE", "substance_class": "reference" } }, { "uuid": "443b7596-0bc1-4087-af95-78a35ccd1ee5", "amount": { "uuid": "3017477e-fb4a-4b92-85f7-14d49e227491" }, "type": "RACEMATE->ENANTIOMER", "related_substance": { "uuid": "ca0bb208-e064-4ae7-9d76-17f2965243cd", "refuuid": "7fd42bf7-c960-43e1-9393-54c73cdd4699", "name": "Epinephrine,(±)-", "unii": "GR0L9S3J0F", "linking_id": "GR0L9S3J0F", "ref_pname": "Epinephrine,(±)-", "substance_class": "reference" } }, { "uuid": "251a23e1-ffc7-42fd-a136-223a649e33ab", "amount": { "uuid": "29136b34-daef-45a7-841e-c73ec94ea1a5", "average": 3970, "high": 5530, "low": 2840, "units": "NANOMOLAR" }, "comments": " Assay in chinese hamster ovary (CHO) cells stably expressing the three β-adrenergic receptor subtypes at comparable leve50 to 80 pM 125I-CYP were used as radioligand. Experiments were done in the presence of 100 µM GTP.", "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "7839cf30-eb58-466b-bb59-b27aeabd7439" ], "related_substance": { "uuid": "63256275-0654-47f1-97ce-5ff45e267a14", "refuuid": "439f9520-949b-423a-b8bc-a7389fc6ba24", "name": "BETA-1 ADRENERGIC RECEPTOR", "unii": "4A4MK4KIB5", "linking_id": "4A4MK4KIB5", "ref_pname": "BETA-1 ADRENERGIC RECEPTOR", "substance_class": "reference" } }, { "uuid": "d41b830c-f3dd-4c55-b15b-43ad51a627f8", "amount": { "uuid": "de9ce23d-6f58-4627-9d81-cdc65067664e", "average": 735, "high": 1050, "low": 510, "units": "NANOMOLAR" }, "comments": " Assay in chinese hamster ovary (CHO) cells stably expressing the three β-adrenergic receptor subtypes at comparable leve50 to 80 pM 125I-CYP were used as radioligand. Experiments were done in the presence of 100 µM GTP.", "qualification": "Ki", "type": "TARGET->AGONIST", "references": [ "7839cf30-eb58-466b-bb59-b27aeabd7439" ], "related_substance": { "uuid": "cb774239-7798-4170-9c63-9ad17f2bf373", "refuuid": "48fe719b-afcc-496a-958b-9130d8f620f4", "name": "BETA-2 ADRENERGIC RECEPTOR", "unii": "VZX139UJO5", "linking_id": "VZX139UJO5", "ref_pname": "BETA-2 ADRENERGIC RECEPTOR", "substance_class": "reference" } }, { "uuid": "2d37693c-0ef3-419a-a1b0-6ed61658a099", "amount": { "uuid": "9ee1493a-d992-4d16-bf76-588b9baa5049" }, "type": "SALT/SOLVATE->PARENT", "related_substance": { "uuid": "8de0669d-ec34-4150-a801-9d77651e1345", "refuuid": "d3deac3e-4110-492e-862d-01779d49e799", "name": "EPINEPHRINE ACETATE", "unii": "M1NJX34RVJ", "linking_id": "M1NJX34RVJ", "ref_pname": "EPINEPHRINE ACETATE", "substance_class": "reference" } }, { "uuid": "0b328e95-7f7c-4128-af2b-7227979eb60e", "amount": { "uuid": "6171481c-0eec-43f5-a80f-969218985d28", "average": 1.2, "units": "MICROMOLAR" }, "qualification": "IC50", "type": "TARGET->AGONIST", "interaction_type": "BINDING", "references": [ "ad3ecfe8-4242-0ae1-befa-365f786b3ec2", "516e0f30-102e-4af7-afa7-58c0904afdd9" ], "related_substance": { "uuid": "c81ff328-920a-47ec-ac8b-540d78e47b16", "refuuid": "602c9a8c-9dbb-46ec-9c81-ff719065f851", "name": "ALPHA-1A ADRENERGIC RECEPTOR", "unii": "3T7136LE8K", "linking_id": "3T7136LE8K", "ref_pname": "ALPHA-1A ADRENERGIC RECEPTOR", "substance_class": "reference" } }, { "uuid": "7d15604e-239c-4c7b-b652-3f5195c25a18", "amount": { "uuid": "9e155b26-5316-4b34-865b-ea894385caac" }, "type": "TARGET->AGONIST", "related_substance": { "uuid": "a3d11e6e-dfa8-450c-8b1f-c62694540f40", "refuuid": "788c1314-b709-4d11-915a-ba8f022f3392", "name": "ALPHA-1B ADRENERGIC RECEPTOR", "unii": "Q7A4S7HOP4", "linking_id": "Q7A4S7HOP4", "ref_pname": "ALPHA-1B ADRENERGIC RECEPTOR", "substance_class": "reference" } }, { "uuid": "c068bc9e-18b7-4dbf-ac73-b7f8ca6a87dc", "amount": { "uuid": "c0e1a500-98af-475e-b463-0f681dc2460b" }, "type": "TARGET->AGONIST", "related_substance": { "uuid": "5e2d1a67-3095-4d31-ac36-3ee4036fc7c8", "refuuid": "6405b2ce-8c41-48ff-873d-e8ddad175f61", "name": "ALPHA-2B ADRENERGIC RECEPTOR", "unii": "93V99BB37L", "linking_id": "93V99BB37L", "ref_pname": "ALPHA-2B ADRENERGIC RECEPTOR", "substance_class": "reference" } }, { "uuid": "ef64a7e6-d47a-4ac9-b601-df62cb7b9eae", "amount": { "uuid": "6f6b843b-62e9-4c41-a41d-9c50d77edb21", "units": "PERCENT PEAK AREA", "high_limit": 0.2 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "4836c49b-ffa4-4753-a3e9-1124d3171c8d", "1d37ae72-daea-4dcb-acc2-0e48199839ed" ], "related_substance": { "uuid": "9097aeb8-af9d-4812-9bea-e68ad2b98fe7", "refuuid": "7173dd49-b6b7-4327-9317-524892d5325b", "name": "NOREPINEPHRINE", "unii": "X4W3ENH1CV", "linking_id": "X4W3ENH1CV", "ref_pname": "NOREPINEPHRINE", "substance_class": "reference" } }, { "uuid": "f208c493-6c9f-4bbb-9d7f-ad07cfe8c36b", "amount": { "uuid": "d649864d-c528-4d93-9b6a-f4314e7b8828", "units": "PERCENT PEAK AREA", "high_limit": 0.2 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "f09e2ba4-0956-4e44-b70c-ddc93e8d53dc", "34fa778d-11dd-4891-b0f4-23ab67738185" ], "related_substance": { "uuid": "2b960367-313b-492d-a00b-ae939d273bde", "refuuid": "8588cd72-fff1-443a-b804-eff7237c4e67", "name": "ADRENALONE", "unii": "EGU41QL329", "linking_id": "EGU41QL329", "ref_pname": "ADRENALONE", "substance_class": "reference" } }, { "uuid": "51979ff2-229f-4883-aa61-b126178553eb", "amount": { "uuid": "b1ba442d-3a74-499d-8db9-a24f3a0d925c", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "comments": "correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity D = 0.7; impurity E = 0.6", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "9ff55d09-4243-4f13-a7c5-c9bb7150938d" ], "related_substance": { "uuid": "29df54da-96c7-452e-8ae7-a816d7da8d71", "refuuid": "3dece6e9-d2c4-481f-ab75-28b413ee9ca8", "name": "N-BENZYL EPINEPHRINE", "unii": "PWO3B7R6YP", "linking_id": "PWO3B7R6YP", "ref_pname": "N-BENZYL EPINEPHRINE", "substance_class": "reference" } }, { "uuid": "9265490a-8a26-4383-aa20-926cb3b26909", "amount": { "uuid": "cfcc31ae-f483-4d3e-a089-f04999be5254", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "comments": "correction factors: for the calculation of content, multiply the peak areas of the following impurities by the corresponding correction factor: impurity D = 0.7; impurity E = 0.6", "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "a5a0cfe2-2cf3-4661-9384-28b40e98d115" ], "related_substance": { "uuid": "15c05bb2-fe67-413a-9c2b-9f1fcbceb40e", "refuuid": "8bf6a0e1-a38f-4774-a062-2e39afe4fd0d", "name": "N-BENZYL ADRENALONE", "unii": "M7UW1YUN32", "linking_id": "M7UW1YUN32", "ref_pname": "N-BENZYL ADRENALONE", "substance_class": "reference" } }, { "uuid": "17033ce2-2014-4725-b0bb-b35107934a69", "amount": { "uuid": "a635cefc-5b6a-40e2-bb36-46de8e0b3b2f", "units": "PERCENT PEAK AREA", "high_limit": 0.2 }, "qualification": "EP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "2a7df67d-275a-4974-bebf-e31d55e0fc77" ], "related_substance": { "uuid": "c04a1f22-8f9f-4926-bb7c-3136bc8e57fa", "refuuid": "a62a5a15-1eca-4af9-a275-f78c25b7c1b7", "name": "EPINEPHRINE SULFONATE", "unii": "B5LB00D4QJ", "linking_id": "B5LB00D4QJ", "ref_pname": "EPINEPHRINE SULFONATE", "substance_class": "reference" } }, { "uuid": "b98498d3-22c0-4435-be19-e12c7a71fac8", "amount": { "uuid": "6fa7cfaa-f02f-4fcd-8f60-9c1b0f20ad8c", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "4500df32-260e-4409-862c-15e811c99151" ], "related_substance": { "uuid": "c5d0fd07-03f6-48be-96c4-10fd30f4af6f", "refuuid": "30d3c90c-b555-40f2-8e83-5fcf923484cc", "name": "4-(1-METHOXY-2-(METHYLAMINO)ETHYL)-1,2-BENZENEDIOL", "unii": "ZO418A31BP", "linking_id": "ZO418A31BP", "ref_pname": "4-(1-METHOXY-2-(METHYLAMINO)ETHYL)-1,2-BENZENEDIOL" } }, { "uuid": "820f5313-325e-4aa4-9e6e-b5c08150eb81", "amount": { "uuid": "54c005f5-ff10-411a-b573-9cd7847a7a66", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "42c3569c-cf3b-4b4e-a438-61cb599eadc1" ], "related_substance": { "uuid": "073326bb-a367-49a0-8237-3fc6e607bb23", "refuuid": "6b747730-0b58-43fa-890a-15520fcdcaa8", "name": "OXEDRINE", "unii": "PEG5DP7434", "linking_id": "PEG5DP7434", "ref_pname": "OXEDRINE" } }, { "uuid": "aadf2839-7c13-4ced-8fa6-1bc0a578a98a", "amount": { "uuid": "2721d5b6-648f-4d48-bd64-fa1718ea5f6d", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "de93fe74-07ce-4732-9dc3-04cdc7c38c36" ], "related_substance": { "uuid": "e2df79d9-a4d0-418c-866d-5dbdc1533a82", "refuuid": "111f56d1-a012-4b99-ae45-6cf9efdbd2e4", "name": "DEOXYEPINEPHRINE", "unii": "R7339QLN1C", "linking_id": "R7339QLN1C", "ref_pname": "DEOXYEPINEPHRINE" } }, { "uuid": "e28eef9a-b40f-4db9-9bfa-d650a1679f6e", "amount": { "uuid": "5645b123-f192-4bed-b484-f99f47f83633", "units": "PERCENT PEAK AREA", "high_limit": 0.2 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "eee5741a-3d81-4234-8ec4-0a3d4d83afc2" ], "related_substance": { "uuid": "5a7c3878-b9af-414a-bff2-f457bac20aed", "refuuid": "7173dd49-b6b7-4327-9317-524892d5325b", "name": "NOREPINEPHRINE", "unii": "X4W3ENH1CV", "linking_id": "X4W3ENH1CV", "ref_pname": "NOREPINEPHRINE", "substance_class": "reference" } }, { "uuid": "517a13ca-f3cb-438f-af9f-6e5a153f9ea0", "amount": { "uuid": "ff8cf014-2da1-49d4-a3b6-267be547a8c7", "units": "PERCENT PEAK AREA", "high_limit": 0.2 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "eee5741a-3d81-4234-8ec4-0a3d4d83afc2" ], "related_substance": { "uuid": "21cf2a10-d661-4494-8b6f-26d2571a34c1", "refuuid": "a62a5a15-1eca-4af9-a275-f78c25b7c1b7", "name": "EPINEPHRINE SULFONATE", "unii": "B5LB00D4QJ", "linking_id": "B5LB00D4QJ", "ref_pname": "EPINEPHRINE SULFONATE", "substance_class": "reference" } }, { "uuid": "defada56-2556-4404-a64b-b6adeea0af28", "amount": { "uuid": "bc647b10-0251-4de1-a7e3-03239b1489cb", "units": "PERCENT PEAK AREA", "high_limit": 0.2 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "eee5741a-3d81-4234-8ec4-0a3d4d83afc2" ], "related_substance": { "uuid": "70970513-6864-41d0-b350-ddca64b9bdec", "refuuid": "8588cd72-fff1-443a-b804-eff7237c4e67", "name": "ADRENALONE", "unii": "EGU41QL329", "linking_id": "EGU41QL329", "ref_pname": "ADRENALONE", "substance_class": "reference" } }, { "uuid": "7cdfcda5-4a6b-49e4-8bd4-55121b7e1b2d", "amount": { "uuid": "8e0bace3-db51-463e-928a-35f2f0fb8451", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "USP", "type": "IMPURITY->PARENT", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "eee5741a-3d81-4234-8ec4-0a3d4d83afc2" ], "related_substance": { "uuid": "7ebeaf1e-1b48-47fc-b490-86d61a24f7b4", "refuuid": "8bf6a0e1-a38f-4774-a062-2e39afe4fd0d", "name": "N-BENZYL ADRENALONE", "unii": "M7UW1YUN32", "linking_id": "M7UW1YUN32", "ref_pname": "N-BENZYL ADRENALONE", "substance_class": "reference" } }, { "uuid": "7df51f17-db01-471c-82ae-d4f2bd949b6b", "amount": { "uuid": "e5825087-5709-4632-8339-ba027f32c3ff", "units": "PERCENT PEAK AREA", "high_limit": 0.1 }, "qualification": "EP", "type": "PARENT->IMPURITY", "interaction_type": "CHROMATOGRAPHIC PURITY (HPLC/UV)", "references": [ "03958e06-9059-9d51-a7e0-53a996065988" ], "related_substance": { "uuid": "6089ce3d-8b9d-4efb-85d3-14d5712b7bd0", "refuuid": "15fc75f0-12de-47af-92d2-aa29d4f19742", "name": "Norepinephrine bitartrate", "unii": "IFY5PE3ZRW", "linking_id": "IFY5PE3ZRW", "ref_pname": "Norepinephrine bitartrate", "substance_class": "reference" } }, { "uuid": "d13f5348-8deb-4f76-9fd8-4541313b976d", "amount": { "uuid": "a31d9bac-4a62-48e6-becc-a6e13b662530" }, "type": "IMPURITY->PARENT", "references": [ "dda18a06-ba93-4fbf-b498-7caf1f8c8415" ], "related_substance": { "uuid": "7f553e25-352c-468a-a9f4-6916678307e5", "refuuid": "6a6f1d5a-a69a-4963-a236-101d81040422", "name": "N-nitroso-epinephrine", "unii": "VN4S737FT3", "linking_id": "VN4S737FT3", "ref_pname": "N-nitroso-epinephrine", "substance_class": "reference" } }, { "uuid": "7ca420f3-d20b-469a-b392-9d2a29c6791a", "amount": { "uuid": "3c4aaf14-f76e-43ea-9337-c8243668373f", "average": 126000, "high": 136000, "low": 116000, "units": "NANOMOLAR" }, "comments": " Assay in chinese hamster ovary (CHO) cells stably expressing the three β-adrenergic receptor subtypes at comparable leve50 to 80 pM 125I-CYP were used as radioligand. Experiments were done in the presence of 100 µM GTP.", "qualification": "Ki", "type": "WEAK AGONIST->TARGET", "references": [ "7839cf30-eb58-466b-bb59-b27aeabd7439" ], "related_substance": { "uuid": "00a75571-b6fa-41f1-9861-afab6967fb72", "refuuid": "000490d0-3890-4382-87d3-0c7687cbbecf", "name": "BETA-3 ADRENERGIC RECEPTOR", "unii": "PG244BS39U", "linking_id": "PG244BS39U", "ref_pname": "BETA-3 ADRENERGIC RECEPTOR", "substance_class": "reference" } }, { "uuid": "4929eabf-3107-4436-b374-cf3ba396572f", "amount": { "uuid": "aada1026-dd78-498f-9602-64d90af52af8" }, "type": "METABOLIC ENZYME->SUBSTRATE", "references": [ "b9c4656f-7458-4161-9a43-c9bf456f2e8e" ], "related_substance": { "uuid": "6ca24d7a-b5e0-4823-bdbc-9edde882733f", "refuuid": "46a76c73-550a-4aab-ad26-460b6a357de9", "name": "CATECHOL O-METHYLTRANSFERASE", "unii": "22Q832K2UN", "linking_id": "22Q832K2UN", "ref_pname": "CATECHOL O-METHYLTRANSFERASE", "substance_class": "reference" } }, { "uuid": "84293db2-fd42-4a25-85e6-2b267bc3a8a0", "amount": { "uuid": "c00ae91b-c36b-40c2-81cb-48dda90358fa", "average": 5.5, "high": 6.7, "low": 4.7, "units": "MICROMOLAR" }, "qualification": "Ki", "type": "TRANSPORTER->SUBSTRATE", "references": [ "0c9273f5-04b2-4a31-8d06-42f27740172e" ], "related_substance": { "uuid": "62db225b-e7af-4bc8-b443-cb4bb52efd29", "refuuid": "f9fe89bd-1392-4773-87c1-d7a117b1a22c", "name": "Chromaffin granule amine transporter", "unii": "5PW6T9YK9P", "linking_id": "5PW6T9YK9P", "ref_pname": "Chromaffin granule amine transporter", "substance_class": "reference" } } ], "names": [ { "uuid": "9b3f2640-af79-4340-a7af-830dc78a85ac", "name": "(-)-(R)-Epinephrine", "stdName": "(-)-(R)-EPINEPHRINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f8c2f7d2-e6b0-4a61-9616-986001b1b81f", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "c3bbb0f1-610a-4134-bdaa-957b9304d8be", "name": "(-)-3,4-Dihydroxy-α-[2-(methylamino)ethyl]benzyl alcohol", "stdName": "(-)-3,4-DIHYDROXY-.ALPHA.-(2-(METHYLAMINO)ETHYL)BENZYL ALCOHOL", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "207eedf5-6b33-4179-8da5-c3256ba4d5e6" ], "display_name": false }, { "uuid": "a56ba7be-c942-4faa-890b-b1d54e30a4a2", "name": "(-)-Epinephrine", "stdName": "(-)-EPINEPHRINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f8c2f7d2-e6b0-4a61-9616-986001b1b81f", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "782b79c3-e698-4208-a30a-01dd40ba01d3", "name": "1,2-Benzenediol, 4-[1-hydroxy-2-(methylamino)ethyl]-, (R)-", "stdName": "1,2-BENZENEDIOL, 4-(1-HYDROXY-2-(METHYLAMINO)ETHYL)-, (R)-", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "207eedf5-6b33-4179-8da5-c3256ba4d5e6" ], "display_name": false }, { "uuid": "e269beb1-166a-4ce4-9a9d-57e1ef50c1db", "name": "4-((1R)-1-HYDROXY-2-(METHYLAMINO)ETHYL)-1,2-BENZENEDIOL", "stdName": "4-((1R)-1-HYDROXY-2-(METHYLAMINO)ETHYL)-1,2-BENZENEDIOL", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "f8c2f7d2-e6b0-4a61-9616-986001b1b81f", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "895b4fd3-b15d-42d3-9b63-be9f560a6807", "name": "ADRENALIN", "stdName": "ADRENALIN", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "7dee21d2-6c68-4039-8544-c8fcdc10c280", "88907120-abe9-4e83-9e5a-2008e8490d10" ], "display_name": false }, { "uuid": "c51648ea-7e48-4128-94d8-ef1df3c89d45", "name": "ADRENALINE", "stdName": "ADRENALINE", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "d19f42ee-5803-4c8d-9224-c7c1574517aa", "ea720735-870c-4b34-b255-dab378081417", "12708f41-8608-4474-a6f2-89d33cc5470c", "207eedf5-6b33-4179-8da5-c3256ba4d5e6", "656a1959-3b43-4ee1-a16b-6914a6cf10fc", "fb9891f4-3438-47d3-bcc8-a7b0c4d1470d" ], "display_name": false }, { "uuid": "411c24da-034a-200b-c2ea-e729eb189d74", "name": "ADRENALINE [EP IMPURITY]", "stdName": "ADRENALINE [EP IMPURITY]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "ea720735-870c-4b34-b255-dab378081417" ], "display_name": false }, { "uuid": "392855d5-e0fc-1331-aebf-930b6756c7c4", "name": "ADRENALINE [EP MONOGRAPH]", "stdName": "ADRENALINE [EP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "03958e06-9059-9d51-a7e0-53a996065988" ], "display_name": false }, { "uuid": "719190fb-5fa5-4c36-b511-9dbff1662039", "name": "ADRENALINE [JAN]", "stdName": "ADRENALINE [JAN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "201ab365-9702-1291-0b53-c9036a25dd7f" ], "display_name": false }, { "uuid": "ebc3f555-8a46-4f10-a76b-7484285d3aef", "name": "ADRENALINE [MART.]", "stdName": "ADRENALINE [MART.]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "fb9891f4-3438-47d3-bcc8-a7b0c4d1470d" ], "display_name": false }, { "uuid": "d1710861-e3a2-4893-aa0e-93a9d0565c5d", "name": "ADRENALINUM", "stdName": "ADRENALINUM", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c3ee0ef4-02bb-467c-a118-40d321ecf18a", "a5604353-c3f5-41e0-8231-9f453677dbd9", "0f7c5e69-4f0e-42fe-ac17-89d7408a7cf7", "7dee21d2-6c68-4039-8544-c8fcdc10c280", "88907120-abe9-4e83-9e5a-2008e8490d10" ], "display_name": false }, { "uuid": "fd6d530b-c5e7-486f-a035-a56617e07be0", "name": "ADRENALINUM [HPUS]", "stdName": "ADRENALINUM [HPUS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c3ee0ef4-02bb-467c-a118-40d321ecf18a", "a5604353-c3f5-41e0-8231-9f453677dbd9" ], "display_name": false }, { "uuid": "6c10d7bd-e7f1-4f61-80ff-d7c57c6721a4", "name": "ANAPEN", "stdName": "ANAPEN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "12708f41-8608-4474-a6f2-89d33cc5470c", "07a707a7-2266-4672-8562-654b2b0816d9" ], "display_name": false }, { "uuid": "dd9d8cb5-b48f-44b4-81bb-4ed60b2e647b", "name": "BENZYL ALCOHOL, 3,4-DIHYDROXY-.ALPHA.-((METHYLAMINO)METHYL)-, (-)-", "stdName": "BENZYL ALCOHOL, 3,4-DIHYDROXY-.ALPHA.-((METHYLAMINO)METHYL)-, (-)-", "type": "sys", "languages": [ "en" ], "preferred": false, "references": [ "f8c2f7d2-e6b0-4a61-9616-986001b1b81f", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "36714d6a-da84-40c7-a694-cabbcead813a", "name": "BRONKAID MIST", "stdName": "BRONKAID MIST", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "12708f41-8608-4474-a6f2-89d33cc5470c", "2e812d15-cdd0-40c6-8cd7-6e79aeabd39a" ], "display_name": false }, { "uuid": "cfb995c6-f5ba-4d6c-ab6e-bfa95b083c0e", "name": "EPINEPHRINE [HSDB]", "stdName": "EPINEPHRINE [HSDB]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "12708f41-8608-4474-a6f2-89d33cc5470c", "1e6d93f5-3541-4489-b18f-ba2e15a7f1bd" ], "display_name": false }, { "uuid": "2cc09313-48ca-4136-9d1c-036e3ba79e3f", "name": "EPINEPHRINE [MI]", "stdName": "EPINEPHRINE [MI]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5f5aa7bd-9fae-405d-8bab-8080c35ea01a", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "31ca4dad-0de2-4a18-8d3e-8c480cbda3ed", "name": "EPINEPHRINE [ORANGE BOOK]", "stdName": "EPINEPHRINE [ORANGE BOOK]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "1d09c33f-4197-459b-a5bb-69f98a85762e" ], "display_name": false }, { "uuid": "ba35eaa0-ea7c-bcc8-a5f3-cd0cc3142d30", "name": "EPINEPHRINE [USP MONOGRAPH]", "stdName": "EPINEPHRINE [USP MONOGRAPH]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "5183b7df-6050-541b-9a7f-ec9606bb0d6f" ], "display_name": false }, { "uuid": "868f33c5-f8da-3871-59ae-c832498d6bff", "name": "EPINEPHRINE [USP-RS]", "stdName": "EPINEPHRINE [USP-RS]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "c4190628-c011-fc7e-68be-fb2353a4db37" ], "display_name": false }, { "uuid": "6a01d42e-c45b-4ca8-a5b8-d8110a6bc623", "name": "EPINEPHRINE [WHO-IP]", "stdName": "EPINEPHRINE [WHO-IP]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a57ed791-c2da-4ccd-a690-f4b5a73e3b48", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "2b4781a7-2be7-49da-9c29-f063e296f87c", "name": "EPINEPHRINUM [WHO-IP LATIN]", "stdName": "EPINEPHRINUM [WHO-IP LATIN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "a57ed791-c2da-4ccd-a690-f4b5a73e3b48", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "ef767e79-e7b5-4350-a076-6bc511c47292", "name": "EPIPEN", "stdName": "EPIPEN", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "8d30f07d-e236-4720-8cbc-d53fdd4603b1", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "b303ab39-a66d-4627-9a37-1885105e3c8f", "name": "Epinephrine", "stdName": "EPINEPHRINE", "type": "of", "languages": [ "en" ], "preferred": false, "references": [ "98caac79-4064-4cb7-905e-991b3b10a671", "fa492250-e584-4ad5-83ab-d71565c3b4e6", "a57ed791-c2da-4ccd-a690-f4b5a73e3b48", "65ad28e9-b032-4a79-b036-72396b594281", "12708f41-8608-4474-a6f2-89d33cc5470c", "928f6519-b307-43ed-95ff-b2003f8dc087", "4c6def24-5228-4b15-b039-8b081d863d82", "d5448efc-a5ce-4e54-9ae9-e861babf16f5", "751006fd-a2ea-4596-b5e7-12638f7067b6", "30674fd0-b3e9-41e5-85ad-cb18c11aaf26", "5f5aa7bd-9fae-405d-8bab-8080c35ea01a", "ff6dfd07-3e5d-4811-a885-fb4c38083bc8", "a6c2071b-840d-49d9-9a61-f7bba9069138", "b248fa0f-86d1-4184-a562-9ed63e28f188", "1e6d93f5-3541-4489-b18f-ba2e15a7f1bd", "1d09c33f-4197-459b-a5bb-69f98a85762e", "ca410787-02cd-43df-8ec6-69067eb73b26", "04a55222-0a1b-47ae-8564-e8fa7edbc84b" ], "display_name": true, "domains": [ "drug" ], "name_orgs": [ { "uuid": "467fb7bd-4e0a-4ad5-9892-69d4ed32f704", "name_org": "INN" } ] }, { "uuid": "733a1570-f422-2a48-86ff-90bd5b5f1d43", "name": "Epinephrine [WHO-DD]", "stdName": "EPINEPHRINE [WHO-DD]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "89496026-ac09-8e5a-f74e-346787dfdd43" ], "display_name": false }, { "uuid": "e3211f21-877c-4b83-a589-d55e8626d33d", "name": "GLAUPOSINE", "stdName": "GLAUPOSINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d67cacab-63eb-4210-be9b-64f551c0631e", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "8b08a6b2-526d-4c19-8320-b339c682e83c", "name": "IONTOCAINE COMPONENT EPINEPHRINE", "stdName": "IONTOCAINE COMPONENT EPINEPHRINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "1cbe8068-a309-4a5d-8789-6f41ee8a1ec5", "ff7e3222-1eeb-426d-a184-3a4aab8bf6b5" ], "display_name": false }, { "uuid": "0633fe56-b119-4abc-acd9-f66eff20cced", "name": "LIDOSITE TOPICAL SYSTEM KIT COMPONENT EPINEPHRINE", "stdName": "LIDOSITE TOPICAL SYSTEM KIT COMPONENT EPINEPHRINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "1cbe8068-a309-4a5d-8789-6f41ee8a1ec5", "ff7e3222-1eeb-426d-a184-3a4aab8bf6b5" ], "display_name": false }, { "uuid": "4e89ba39-aeb8-400a-aee0-64f289ecba06", "name": "NEFFY", "stdName": "NEFFY", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "41d3f380-a535-4d54-b4a9-ac124af3065b" ], "display_name": false }, { "uuid": "2b622e20-95fd-4cbc-8f60-e1b5e589f4ec", "name": "NEPHRIDINE", "stdName": "NEPHRIDINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "d67cacab-63eb-4210-be9b-64f551c0631e", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "27204804-647b-190c-caed-13d41567947a", "name": "NORADRENALINE TARTRATE IMPURITY A [EP IMPURITY]", "stdName": "NORADRENALINE TARTRATE IMPURITY A [EP IMPURITY]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "03958e06-9059-9d51-a7e0-53a996065988" ], "display_name": false }, { "uuid": "2b022ab3-6bcf-4728-8d3a-9899c9c15fd3", "name": "NSC-62786", "stdName": "NSC-62786", "type": "cd", "languages": [ "en" ], "preferred": false, "references": [ "d67cacab-63eb-4210-be9b-64f551c0631e", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "be135b23-2ef3-4cf1-abc2-69c1e2801ab9", "name": "OCTOCAINE COMPONENT EPINEPHRINE", "stdName": "OCTOCAINE COMPONENT EPINEPHRINE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "1cbe8068-a309-4a5d-8789-6f41ee8a1ec5", "ff7e3222-1eeb-426d-a184-3a4aab8bf6b5" ], "display_name": false }, { "uuid": "ff4ee37a-86fc-4eee-af83-e541b324f0ee", "name": "PRIMATENE MIST", "stdName": "PRIMATENE MIST", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "12708f41-8608-4474-a6f2-89d33cc5470c", "07a707a7-2266-4672-8562-654b2b0816d9" ], "display_name": false }, { "uuid": "db801c2e-7913-44ac-aff4-63dd534b1710", "name": "RACEPINEFRINE, (R)-", "stdName": "RACEPINEFRINE, (R)-", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "f8c2f7d2-e6b0-4a61-9616-986001b1b81f", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "8074ad4c-a6a2-403e-a210-ffab48e4f785", "name": "SUS-PHRINE", "stdName": "SUS-PHRINE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "12708f41-8608-4474-a6f2-89d33cc5470c", "07a707a7-2266-4672-8562-654b2b0816d9" ], "display_name": false }, { "uuid": "90ee4311-e973-47f6-8478-79c4f155ff91", "name": "SUS-PHRINE SULFITE-FREE", "stdName": "SUS-PHRINE SULFITE-FREE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "12708f41-8608-4474-a6f2-89d33cc5470c", "2e812d15-cdd0-40c6-8cd7-6e79aeabd39a" ], "display_name": false }, { "uuid": "99c6d62b-4a98-4d98-b48c-c7c170875400", "name": "SUS-PHRINE SULPHITE-FREE", "stdName": "SUS-PHRINE SULPHITE-FREE", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "7999319a-8fe6-4644-bb1c-5cc5030b674e" ], "display_name": false }, { "uuid": "b33bece6-8f0c-4856-ad21-47ae51d57b10", "name": "SUSPHRINE", "stdName": "SUSPHRINE", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "12708f41-8608-4474-a6f2-89d33cc5470c", "88c3f270-40fb-421b-b6f7-256009e5f6c4" ], "display_name": false }, { "uuid": "c9750533-aaaa-4e58-8158-bfafac1b0c95", "name": "SYMJEPI", "stdName": "SYMJEPI", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "95a25dff-f394-aea4-6c23-f472d41ce9db" ], "display_name": false }, { "uuid": "d588a175-35bc-46f9-9c2e-58cf7cd35f09", "name": "TWINJECT", "stdName": "TWINJECT", "type": "bn", "languages": [ "en" ], "preferred": false, "references": [ "eb7ca244-8071-4c72-bbf9-1bcfc53e71ac", "12708f41-8608-4474-a6f2-89d33cc5470c" ], "display_name": false }, { "uuid": "8b1310a0-aaa1-4430-be78-0e0286bfb965", "name": "epinephrine [INN]", "stdName": "EPINEPHRINE [INN]", "type": "cn", "languages": [ "en" ], "preferred": false, "references": [ "4c6def24-5228-4b15-b039-8b081d863d82" ], "display_name": false } ], "modifications": { "uuid": "096a434a-53cd-4719-b90f-1ef451579997" } } ] }